Literature DB >> 20876733

Neurofibromatosis-1 regulates neuroglial progenitor proliferation and glial differentiation in a brain region-specific manner.

Da Yong Lee1, Tu-Hsueh Yeh, Ryan J Emnett, Crystal R White, David H Gutmann.   

Abstract

Recent studies have shown that neuroglial progenitor/stem cells (NSCs) from different brain regions exhibit varying capacities for self-renewal and differentiation. In this study, we used neurofibromatosis-1 (NF1) as a model system to elucidate a novel molecular mechanism underlying brain region-specific NSC functional heterogeneity. We demonstrate that Nf1 loss leads to increased NSC proliferation and gliogenesis in the brainstem, but not in the cortex. Using Nf1 genetically engineered mice and derivative NSC neurosphere cultures, we show that this brain region-specific increase in NSC proliferation and gliogenesis results from selective Akt hyperactivation. The molecular basis for the increased brainstem-specific Akt activation in brainstem NSCs is the consequence of differential rictor expression, leading to region-specific mammalian target of rapamycin (mTOR)/rictor-mediated Akt phosphorylation and Akt-regulated p27 phosphorylation. Collectively, these findings establish mTOR/rictor-mediated Akt activation as a key driver of NSC proliferation and gliogenesis, and identify a unique mechanism for conferring brain region-specific responses to cancer-causing genetic changes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20876733      PMCID: PMC2956210          DOI: 10.1101/gad.1957110

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  59 in total

1.  Lack of the cell-cycle inhibitor p27Kip1 results in selective increase of transit-amplifying cells for adult neurogenesis.

Authors:  Fiona Doetsch; Jose Manuel-Garcia Verdugo; Isabelle Caille; Arturo Alvarez-Buylla; Moses V Chao; Patrizia Casaccia-Bonnefil
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

2.  Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas.

Authors:  D H Gutmann; J Donahoe; T Brown; C D James; A Perry
Journal:  Neuropathol Appl Neurobiol       Date:  2000-08       Impact factor: 8.090

3.  N-CoR controls differentiation of neural stem cells into astrocytes.

Authors:  Ola Hermanson; Kristen Jepsen; Michael G Rosenfeld
Journal:  Nature       Date:  2002-10-16       Impact factor: 49.962

4.  Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export.

Authors:  Noriko Ishida; Taichi Hara; Takumi Kamura; Minoru Yoshida; Keiko Nakayama; Keiichi I Nakayama
Journal:  J Biol Chem       Date:  2002-03-11       Impact factor: 5.157

5.  Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo.

Authors:  M Groszer; R Erickson; D D Scripture-Adams; R Lesche; A Trumpp; J A Zack; H I Kornblum; X Liu; H Wu
Journal:  Science       Date:  2001-11-01       Impact factor: 47.728

6.  Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas.

Authors:  Yoshitaka Narita; Motoo Nagane; Kazuhiko Mishima; H-J Su Huang; Frank B Furnari; Webster K Cavenee
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

7.  Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.

Authors:  N Lau; M M Feldkamp; L Roncari; A H Loehr; P Shannon; D H Gutmann; A Guha
Journal:  J Neuropathol Exp Neurol       Date:  2000-09       Impact factor: 3.685

8.  Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.

Authors:  Naoya Fujita; Saori Sato; Kazuhiro Katayama; Takashi Tsuruo
Journal:  J Biol Chem       Date:  2002-05-31       Impact factor: 5.157

Review 9.  Glioma stem cells: a midterm exam.

Authors:  Charles D Stiles; David H Rowitch
Journal:  Neuron       Date:  2008-06-26       Impact factor: 17.173

10.  Neural stem cell lineages are regionally specified, but not committed, within distinct compartments of the developing brain.

Authors:  Seiji Hitoshi; Vincent Tropepe; Marc Ekker; Derek van der Kooy
Journal:  Development       Date:  2002-01       Impact factor: 6.868

View more
  63 in total

Review 1.  Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.

Authors:  Karl Staser; Feng-Chun Yang; D Wade Clapp
Journal:  Annu Rev Pathol       Date:  2011-11-07       Impact factor: 23.472

Review 2.  Deconvoluting mTOR biology.

Authors:  Jason D Weber; David H Gutmann
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

3.  Evidence for and against regional differences in neural stem and progenitor cells of the CNS.

Authors:  Oren J Becher; Eric C Holland
Journal:  Genes Dev       Date:  2010-10-15       Impact factor: 11.361

Review 4.  Intracellular and intercellular signaling networks in cancer initiation, development and precision anti-cancer therapy: RAS acts as contextual signaling hub.

Authors:  Peter Csermely; Tamás Korcsmáros; Ruth Nussinov
Journal:  Semin Cell Dev Biol       Date:  2016-07-06       Impact factor: 7.727

5.  Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target.

Authors:  Marianne Hütt-Cabezas; Matthias A Karajannis; David Zagzag; Smit Shah; Iren Horkayne-Szakaly; Elisabeth J Rushing; J Douglas Cameron; Deepali Jain; Charles G Eberhart; Eric H Raabe; Fausto J Rodriguez
Journal:  Neuro Oncol       Date:  2013-11-06       Impact factor: 12.300

6.  NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.

Authors:  Joseph A Toonen; Corina Anastasaki; Laura J Smithson; Scott M Gianino; Kairong Li; Robert A Kesterson; David H Gutmann
Journal:  Hum Mol Genet       Date:  2016-02-16       Impact factor: 6.150

Review 7.  Report from the fifth National Cancer Institute Mouse Models of Human Cancers Consortium Nervous System Tumors Workshop.

Authors:  David H Gutmann; Charles D Stiles; Scott W Lowe; Gideon E Bollag; Frank B Furnari; A L Charest
Journal:  Neuro Oncol       Date:  2011-07       Impact factor: 12.300

8.  Activated k-ras, but not h-ras or N-ras, regulates brain neural stem cell proliferation in a raf/rb-dependent manner.

Authors:  R Hugh F Bender; Kevin M Haigis; David H Gutmann
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

9.  ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.

Authors:  Yuan Wang; Edward Kim; Xiaojing Wang; Bennett G Novitch; Kazuaki Yoshikawa; Long-Sheng Chang; Yuan Zhu
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

10.  Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner.

Authors:  Aparna Kaul; Yi-Hsien Chen; Ryan J Emnett; Sonika Dahiya; David H Gutmann
Journal:  Genes Dev       Date:  2012-11-14       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.